Bio Break: Pros and Cons of Platform Technologies in Medical Device Development

Resources

Bio Break: Pros and Cons of Platform Technologies in Medical Device Development

Topic: Bio Break

In this engaging episode of Bio Break, Nick and Joris dive into the complex world of platform technologies in product development, exploring the pros and cons of this widely discussed concept. From in-vitro diagnostics to point-of-care instruments, the term “platform” often sparks excitement—and sometimes hesitation. But what does it truly mean to build a platform-based product, and when does it make sense?

Nick opens the discussion by explaining why the word “platform” can be a trigger for product developers. While the idea of creating a flexible system with multiple applications is appealing, it often risks diluting the target product profile. He highlights the importance of focusing on specific customer needs and ensuring the product solves a defined problem effectively, rather than spreading resources thin across hypothetical use cases.

Joris counters with examples of successful platform technologies in the in-vitro diagnostics space. Systems that can handle various tests, from blood panels to infectious disease assays, have proven invaluable in centralized diagnostic labs. Their ability to save space and streamline workflows makes them indispensable. However, Joris also points out the market risks of trying to cater to diverse customer bases—such as health-conscious individuals versus clinical labs—within a single platform, which can dilute the product’s focus and usability.

The duo discusses the importance of considering market segmentation and customer needs during the design phase. For centralized labs, having a multi-functional platform is critical, but in point-of-care environments, simpler, targeted devices may be more practical. They wrap up by emphasizing the value of aligning product design with a well-defined target product profile.

If you’re curious about how platform technologies can transform medical device development—or when they might lead to pitfalls—this episode offers a balanced perspective packed with real-world insights.

Discover:

  • How to align product design with market needs.
  • The pros and cons of platform-based designs.
  • Key differences between centralized diagnostics and point-of-care tools.

Pros and Cons of Platform Technologies in Medical Device Development

YouTube video thumbnail
A vial of orange liquid with a radiation symbol and a syringe sit on a reflective metal surface in front of a large medical imaging machine. The overlay text reads: "Radioactive. On Purpose?" in bold black font on a white rounded background.

Radiopharmaceutical device development is gaining momentum as medical teams explore new frontiers in diagnostic imaging and cancer treatment.

A gloved hand holds a COVID-19 lateral flow test in front of a white bathroom sink and tiled wall. Overlay text reads: ‘From ELISA to DIY?’ in bold white font on a black background.

Nick Allan and Nigel Syrotuck reflect on recent ADLM diagnostics innovation and how it has shaped the future of clinical testing.

loved hand holding a blood vial in front of blurred Chicago skyline. Overlay text says ‘From vial… To Chicago?’ in bold white font on black background.

Each summer, the laboratory diagnostics showcase hosted by the Association for Diagnostics & Laboratory Medicine (ADLM) draws industry leaders to Chicago.

Thumbnail showing a vial of clear contrast agent on the left, with a red dotted arrow pointing to an X-ray image of a skull displayed on a tablet held by a person in a white coat. Overlay text reads “Not approved here?” in bold black and white text.

Nigel and Nick explore how contrast agents in imaging support medical device trials and diagnostics. While bones appear clearly in standard X-rays, soft tissues like those in the nasal cavity often require contrast agents to become visible.